Registration

Welcome Remarks

Robert Fergusson, Representative, Australian Office

Opening Remarks

Dr Chung-Hsiun Wu
Chairman, Taiwan Bio Industry Organisation

Keynote:
Australia – A powerhouse for science and innovation in Biotechnology

Helen Dai, Trade and Investment Commissioner, Australia Trade and Investment

Group Photo

Panel Discussion:
Australia’s Clinical Trial Capabilities - Insights from Australian Industry Leaders

Moderator:

• David Lloyd, Managing Director, Southern Star Research

Panellists:

• Yvonne Lungershausen, CEO, Avance
• John Lin, Taiwan Country Manager, George Clinical
• Robert Lin, President, Greenlight
• Yooni Kim, Vice President, Global Head of Clinical Trials Service, Novotech
• Robert Lin, CEO, GreenLight Clinical
• Ya-Han Chang, Vice President Commercial Strategy, HiRO

Panel Discussion: 
World-Class  Clinical Trial Facilities - Practical Experiences Sharing from Clinical Trial Sites

Moderator: 

• Yvonne Lungershausen, CEO, Avance

Panellists:

• Chris Saracini, Business Development Officer, CMAX
• Jeffery Wong, Senior Director, Nucleus Network
• Chris Stellatos, Director, Scientia Clinical Research
• Tam C. Nguyen, Deputy Director of Research, St. Vincent’s Hospital (Melbourne)

Tea break

Case Study- Success Story from a Taiwanese Biotech

Panel Discussion:
Maximising Clinical Trials Efficiency - Intelligence from Clinical Associated Service Providers

Moderator: 

• Tam C. Nguyen, Deputy Director of Research, St. Vincent Hospital

Panellists：

• Sharon Sim, Senior Business Development Manager, 360biolabs
• Amelia Wee, Senior Business Development Manager, Agilex Biolabs
• Clara Ya, Business Development Executive, PCI
• Minh-Thu Cao Xuan, Business Development Manager, TrialKey

Panel Discussion:
Levering R&D Incentive Program – Best Practices Sharing from Health Corporate Service
Providers

Moderator: 

• Jeffery Wong, Senir Director, Nucleus Network

Panellists:

• Luis Silva, Regional Business Development Manager, Acclime Australia
• Pavel Reddy, R&D Tax Advisor, Global R&D

Panel Discussion:
Next-Generation Therapies through Innovative Solutions between Australia and Taiwan

Moderator: 

• Michael Huang, Director, BPIPO & Vice President, Innovation and Entrepreneur Core, DCB

Panellists：

• Afsar Ahmed, Chief Scientific Officer, Aeterna
• Andrea Wang, CEO, AHEAD Medicine Corporation
• Yi-Lun Chiang, Business Development Manager, BRIM Biotechnology Inc
• Patty Sung, President & COO, Intelligene
• Authur Lung, CEO, NaviFUS Corp

The morning session concludes

Lunch

One-on-One meetings

Registration

Opening Remarks

BIO Asia Awards-Successful Stories

Cultivate Business Growth by Listing on TWSE

Peter Chuang, Assistant Manager, Taiwan Stock Exchange Corporation

Development and Applications of Gen AI in Clinical Research

Tong Guo, Vice President, Head of Sales, Greater China, IQVIA

Break

Speaker:
Mr. Florian Vanlangendonck,
Technical Operations Leader, IBA

Regional Collaboration Summit-Partnership, Collaboration & Synergy

Representative from Australia, Japan, Belgium, Malaysia, and Thailand

Closing

Registration and networking

Opening Remarks:
Belgium – The Health & Biotech Valley, In the heart of Europe 
Today and Tomorrow

Mr. Matthieu Branders, Director of Belgian Office Taipei

Flanders Life Sciences - A Thriving Combination of Biotech and Pharma

Speaker:Speaker: Mrs. Els Verhulst, Science & Technology Counselor
FLANDERS INVESTMENT & TRADE, Embassy of Belgium in Tokyo, Japan

Biocovergence: how the intersection of biology and technology advance human health 

Speaker:
Dr. Paru Deshpande
Vice President R&D, Life Science Technologies, imec

IBA’s Proton Therapy and Pharma Solutions

Speaker:
Mr. Florian Vanlangendonck,
Technical Operations Leader, IBA

Revolutionizing the diagnosis and monitoring of diseases by advancing the science of epigenetics - Volition’s nucleosome quantification technology (Nu.Q®)
 

Speaker:
Dr. Jasmine Kway, CEO Volition Asia

Q&A and Networking time

Opening Remarks 

Prof. Yoshiaki Tsukamoto
Session Chair; Executive Director, Japan Bioindustry Association

Opening Remarks 

Dr. Michael Huang
Director of Biotechnology and Pharmaceutical Industries Promotion
Office, Ministry of Economic Affairs, Taiwan

Bioecosystem in Japan

Prof. Yoshiaki Tsukamoto
Session Chair; Executive Director, Japan Bioindustry Association

Takeda’s Partnering Strategy to Access Emerging Innovations across Asia-Pacific

Masanori Sato
Head, Center for External Innovation Japan/APAC,
Takeda Pharmaceutical Company Limited

Takeda’s Partnering Strategy to Access Emerging Innovations across Asia-Pacific

Masanori Sato
Head, Center for External Innovation Japan/APAC,
Takeda Pharmaceutical Company Limited

Business expansion at AGC Biologics and collaboration with partners

Shigeru Kunii
Senior Director, Head of Business Development, Asia, AGC Biologics

Partners For Life, Expansion of FUJIFILM's Lifesciences Business in Asia

Takeshi Yamamoto
Corporate Vice president. Deputy General Manager, Lifescience
strategy HQ. General Manager, Bioscience & Engineering laboratories, FUJIFILM

Latest topics in Japanese life science innovation ecosystem

Prof. Akihiko Soyama
CEO, Life Science Innovation Network Japan

Panel Discussion

Moderator:

• Prof. Yoshiaki Tsukamoto, Executive Director, Japan Bioindustry Association

Panelists:

• Dr. Michael Huang, Director of Biotechnology and Pharmaceutical​ Industries Promotion Office, Ministry Of Economic Affairs, Taiwan
• Masanori Sato, Head, Center for External Innovation Japan/APAC,Takeda Pharmaceutical Company Limited
• Shigeru Kunii, Senior Director, Head of Business Development, Asia, AGC Biologics
• Takeshi Yamamoto, Corporate vice president. Deputy GeneralManager, Lifescience strategy HQ. General Manager, Bioscience &Engineering laboratories, FUJIFILM
• Prof. Akihiko Soyama, CEO, Life Science Innovation Network Japan

Opening Remarks 

Dr. Shiing-Jer Twu
Chairman, Development Center for Biotechnology

Opening Remarks 

Mr. Narong Boonsatheanwong
Executive Director, Thailand Trade and Economic Office

Delivering essential medicine and vaccine via transdermal

Mr. Veerachat Petpisit, MD
CEO, Mineed Technology Co., Ltd, Thailand

Perspective of precision health and next generation probiotics

Dr.Cheng-Chih (Richard) Hsu
CEO, Leeuwenhoek Laboratories Co. Ltd.  

Introduction of SciVision Biotech

Ms. Janet Wang
Business Development Representative, SciVision Biotech Inc.

Human leukocyte antigen (HLA) Testing for Pharmacogenetics

Ms. Thitiporn Mooksombat
Chief Strategy Officer, MP Group (Thailand) Co. Ltd.

Accelerated computing platform empowering healthcare providers to accelerate healthcare transformation with multi-omics technologies, bridging the gaps in diagnostic demands throughout patient journey

Allen Chang
CEO & EVP of Business Development, Atgenomix

Entering the Cancer Arena: The Birth of  Avatar Medicine

Mr. Po Chen,
Founder & CEO, CancerFree Biotech, Taiwan

Panel Discussion or Conclusion

Moderator: 

• Dr. Nares Damrongchai, Co-Founder, Accel Group Co., Ltd.

Panelists:

• Mr. Veerachat Petpisit, MD, CEO, Mineed Technology Co., Ltd, Thailand
• Thitiporn Mooksombat, Chief Strategy Officer, MP Group (Thailand) Co. Ltd.
• Dr.Cheng-Chih (Richard) Hsu, CEO, Leeuwenhoek Laboratories Co. Ltd.
• Allen Chang, CEO & EVP of Business Development, Atgenomix
• Mr. Po Chen, Founder & CEO, CancerFree Biotech, Taiwan
• Ms. Janet Wang, Business Development Representative, SciVision Biotech Inc.

Registration

Welcoming Remarks

Madam Aznifah Isnariah Abdul Ghani
President
Malaysian Friendship and Trade Centre (MFTC)

Appreciation to speakers & group photo

Malaysia Vaccine Project Office (MVPO) (TBC)

Company Presentation 1:

Mr. Chin Kok Tian
Managing Director of My Myracle Sdn Bhd

Company Presentation 2:

Madam Haliza Binti Ramli
Acting Chief Executive Officer of Biotropics Malaysia Berhad

Company Presentation 3:

Mr. Fadzhairi Jabar
Chief Executive Officer of Arcadia Life Sciences Sdn Bhd

Topic: Taiwan-Malaysia: Opportunities for Pharmaceutical Industry Linkage and Business Collaboration

Guest Speaker:
Taiwan Medical & Pharmaceutical Industry Technology & Development Centre

Q&A session

End of program / Networking session